JUPITER, Fla., Nov. 26, 2012 /PRNewswire/ -- BioRestorative Therapies, Inc. (“BRT” or the “Company”) (OTC BB: BRTX), a life sciences company focused on stem cell based cellular therapies for various personal medical applications, announced today that it has launched a new website, available at www.biorestorative.com.
The new site highlights BRT as an innovator and pioneer in the adult stem cell industry. The Company’s two primary programs, the brtxDISC Program and the ThermoStem Program, are both presented in more detail on the website, along with rich imagery and information about therapies being developed. Additionally, the site provides investors easy access to corporate information, including the Company’s stock (OTC BB: BRTX).
Mark Weinreb, Chief Executive Officer of BRT, commented, “We are very excited about launching our new website, as it provides a thorough representation of the Company’s scientific initiatives and business. It’s easy to navigate and allows the user to become familiar with the steps we are taking to grow as an innovative, cutting edge developer of medical procedures. We are pleased to invite interested parties to visit our site to learn more about our research efforts and therapeutic programs.”
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (“BRT”) develops medical procedures using cell and tissue protocols, primarily involving adult stem cells (non-embryonic), and allowing patients to undergo minimally invasive cellular-based treatments. BRT is developing the following scientific initiatives: Our brtxDISC Program (Disc Implanted Stem Cells) offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. Our ThermoStemProgram focuses on treatments for metabolic disorders (diabetes, heart disease, etc.) and obesity and uses brown fat stem cells. Initial research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels in the body. The Company also offers plant stem cell-based facial creams and products under the Stem Pearls® brand at www.stempearls.com. For more information about BRT, please visit www.biorestorative.com.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company’s Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.
Investor Contacts:
KCSA Strategic Communications
Philip Carlson / Josh Dver
+1 212.896.1233 / +1 212.896.1239
pcarlson@kcsa.com / jdver@kcsa.com
SOURCE BioRestorative Therapies, Inc.